191 related articles for article (PubMed ID: 26977031)
1. Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.
Jiang L; Li P; Gong Z; Hu B; Ma J; Wang J; Chu H; Zhang L; Sun P; Chen J
Anticancer Res; 2016 Mar; 36(3):1313-8. PubMed ID: 26977031
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
3. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
SHI Z; HE QY; HUA BJ
Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of bevacizumab combined with cisplatin in the treatment of malignant pleural effusion and ascites caused by lung cancer: a randomized trial.
Zhou Z; Li H; Hu D; Xie L
Ann Palliat Med; 2021 Oct; 10(10):10575-10583. PubMed ID: 34763504
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
Zhao WY; Chen DY; Chen JH; Ji ZN
Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
[TBL] [Abstract][Full Text] [Related]
6. Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.
Chu H; Du F; Gong Z; Lian P; Wang Z; Li P; Hu B; Chi C; Chen J
Anticancer Res; 2017 Aug; 37(8):4587-4591. PubMed ID: 28739756
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
8. A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusion.
Moon YW; Choi ST; Cho BC; Choi HJ; Kim YT
Yonsei Med J; 2007 Dec; 48(6):1035-8. PubMed ID: 18159598
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial.
Zhao H; Li X; Chen D; Cai J; Fu Y; Kang H; Gao J; Gao K; Du N
Med Oncol; 2015 Feb; 32(2):292. PubMed ID: 25609006
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861.
Figlin R; Mendoza E; Piantadosi S; Rusch V
Chest; 1994 Dec; 106(6 Suppl):363S-366S. PubMed ID: 7988265
[TBL] [Abstract][Full Text] [Related]
12. [Intrapleural DDP and systemic thiosulfate rescue in the treatment of malignant pleural effusion].
Hua X; Lu W; Duan G
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):50-2. PubMed ID: 7656790
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: a randomized prospective study.
Chen WJ; Yuan SF; Yan QY; Xiong JP; Wang SM; Zheng WE; Zhang W; Sun HY; Chen H; Wu LL
Cancer Invest; 2012 Feb; 30(2):126-30. PubMed ID: 22148972
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.
Huang XE; Wei GL; Huo JG; Wang XN; Lu YY; Wu XY; Liu J; Xiang J; Feng JF
Asian Pac J Cancer Prev; 2013; 14(4):2611-4. PubMed ID: 23725184
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial.
Liu L; Zhang T; Song X; Liao CG; Xu T; Yang Y; Zeng M; Jia J; Su H; Song Y; Min J; Zhang H; Li W; Zhang H; Zhang H
Int J Hyperthermia; 2023; 40(1):2241689. PubMed ID: 37574198
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection (observation of 60 cases)].
Zhang Z; Li D; Wu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):29-31. PubMed ID: 11802935
[TBL] [Abstract][Full Text] [Related]
19. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
20. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
Chen L; Zhu X; Li D; Cai X
J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]